TY - JOUR
T1 - Genetic analysis of dilated cardiomyopathy hla and immunoglobulin genes may confer susceptibility
AU - Koga, Yoshinori
AU - Toshima, Hironori
AU - Nishi, Hirofumi
AU - Nishi, Hirofumi
AU - Sasazuki, Takehiko
AU - Kimura, Akinori
AU - Fukuta, Shinji
AU - Kusukawa, Reizo
AU - Kawamura, Keishiro
AU - Nimura, Yasuharu
AU - Nagano, Makoto
AU - Yasuda, Hisakazu
AU - Kawai, Chuichi
AU - Sugimoto, Tsuneaki
AU - Okada, Ryozo
AU - Yazaki, Yoshio
AU - Tanaka, Hiromitsu
AU - Harumi, Kenichi
PY - 1992
Y1 - 1992
N2 - To identify genetic factors in the immune system which control the susceptibility to dilated cardiomyopathy (DCM), HLA class II DNA typing was performed in 61 Japanese patients, using PCR/SSO probe analyses. The frequencies of HLA-DQB1∗0503 (15% vs 5%; RR=3.06, X2=7.19) and DQB1∗0604 (21% vs 10%; RR=2.41, X2=6.20) were significantly increased and that of HLA-DQB1∗0502 (RR=1.74) was slightly increased in the DCM patients. The frequency of DQB1∗0303 (16% vs 31%; RR=0.44, X2=5.16) was significantly decreased in the patients. The increased HLA-DQB1 alleles have a histidine residue in common at the 30th codon for the HLA-DQB1 chain. Among the genetic markers studied by Southern blot analyses, IGLV (immunoglobulin lambda light chain, pV3.3) showed a strong association with DCM, i.e. A2/A2 genotype was found in 37.7% of patients whereas it was observed in only 18.9% of the control subjects (RR=2.6, X2=7.77). The frequency of this genotype was higher in patients under age 45 years at the time of diagnosis (45.5%, RR=3.6, X2=10.02). These results suggest that HLA and immunoglobulin genes are closely linked to susceptibility to DCM.
AB - To identify genetic factors in the immune system which control the susceptibility to dilated cardiomyopathy (DCM), HLA class II DNA typing was performed in 61 Japanese patients, using PCR/SSO probe analyses. The frequencies of HLA-DQB1∗0503 (15% vs 5%; RR=3.06, X2=7.19) and DQB1∗0604 (21% vs 10%; RR=2.41, X2=6.20) were significantly increased and that of HLA-DQB1∗0502 (RR=1.74) was slightly increased in the DCM patients. The frequency of DQB1∗0303 (16% vs 31%; RR=0.44, X2=5.16) was significantly decreased in the patients. The increased HLA-DQB1 alleles have a histidine residue in common at the 30th codon for the HLA-DQB1 chain. Among the genetic markers studied by Southern blot analyses, IGLV (immunoglobulin lambda light chain, pV3.3) showed a strong association with DCM, i.e. A2/A2 genotype was found in 37.7% of patients whereas it was observed in only 18.9% of the control subjects (RR=2.6, X2=7.77). The frequency of this genotype was higher in patients under age 45 years at the time of diagnosis (45.5%, RR=3.6, X2=10.02). These results suggest that HLA and immunoglobulin genes are closely linked to susceptibility to DCM.
UR - http://www.scopus.com/inward/record.url?scp=0026716819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026716819&partnerID=8YFLogxK
U2 - 10.1253/jcj.56.1054
DO - 10.1253/jcj.56.1054
M3 - Article
C2 - 1359165
AN - SCOPUS:0026716819
SN - 0047-1828
VL - 56
SP - 1054
EP - 1061
JO - JAPANESE CIRCULATION JOURNAL
JF - JAPANESE CIRCULATION JOURNAL
IS - 10
ER -